Giulia Rotta

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Obstructive Sleep Apnea

Top Venues

EMBO molecular medicine

Bioconjugate chemistry

Molecular cancer therapeutics

Nanoscale advances

This page only lists publications with an associated author ORCID identifier.

Publications

Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine (2024)
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Sébastien Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel, Roberto De Luca, Markus Gabriel Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer. Molecular cancer therapeutics 23 (7) (2024)
Giulia Rotta, Emanuele Puca, Samuele Cazzamalli, Dario Neri, Sheila Dakhel
Cytokine Biopharmaceuticals with "Activity-on-Demand" for Cancer Therapy. Bioconjugate chemistry 35 (8) (2024)
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Sébastien Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel, Roberto De Luca, Markus Gabriel Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Optimizing the design and geometry of T cell engaging bispecific antibodies targeting CEA in colorectal cancer. Molecular cancer therapeutics (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Giulia Rotta, Emanuele Puca, Samuele Cazzamalli, Dario Neri, Sheila Dakhel
Cytokine Biopharmaceuticals with "Activity-on-Demand" for Cancer Therapy. Bioconjugate chemistry (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Aureliano Zana, Claudia Puig-Moreno, Matilde Bocci, Ettore Gilardoni, Cesare Di Nitto, Lucrezia Principi, Domenico Ravazza, Giulia Rotta, Eleonora Prodi, Roberto De Luca, Dario Neri, Samuele Cazzamalli
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule-Drug, Antibody-Drug, and Peptide-Drug Conjugates. Bioconjugate chemistry (2023)
Lodovico Gatti, Cristina Chirizzi, Giulia Rotta, Pietro Milesi, María Sancho-Albero, Victor Sebastian Cabeza, Anna Mondino, Jesús Santamaría, Pierangelo Metrangolo, Linda Chaabane, Francesca Baldelli Bombelli
Pivotal role of the protein corona in the cell uptake of fluorinated nanoparticles with increased sensitivity for 19 F-MR imaging. Nanoscale advances 5 (14) (2023)
Louis Plüss, Frederik Peissert, Abdullah Elsayed, Giulia Rotta, Jonas Römer, Sheila Dakhel, Alessandra Villa, Emanuele Puca, Roberto De Luca, Annette Oxenius, Dario Neri
Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen. mAbs 15 (1) (2023)